Anaptysbio (ANAB) Enterprise Value (2016 - 2025)
Anaptysbio (ANAB) has disclosed Enterprise Value for 10 consecutive years, with -$311.6 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 19.13% year-over-year to -$311.6 million, compared with a TTM value of -$311.6 million through Dec 2025, up 19.13%, and an annual FY2025 reading of -$311.6 million, up 19.13% over the prior year.
- Enterprise Value was -$311.6 million for Q4 2025 at Anaptysbio, down from -$249.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$249.0 million in Q3 2025 and bottomed at -$548.1 million in Q4 2021.
- Average Enterprise Value over 5 years is -$387.2 million, with a median of -$390.9 million recorded in 2021.
- The sharpest move saw Enterprise Value plummeted 77.91% in 2022, then skyrocketed 42.12% in 2025.
- Year by year, Enterprise Value stood at -$548.1 million in 2021, then rose by 19.5% to -$441.2 million in 2022, then rose by 11.41% to -$390.9 million in 2023, then increased by 1.41% to -$385.4 million in 2024, then increased by 19.13% to -$311.6 million in 2025.
- Business Quant data shows Enterprise Value for ANAB at -$311.6 million in Q4 2025, -$249.0 million in Q3 2025, and -$265.7 million in Q2 2025.